Presented promising PK, pharmacodynamic, and safety results for Decoy20 at the American Society for Clinical Oncology (ASCO) and the Society for Immunotherapy of Cancer (SITC) annual meetings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback